NovaBridge Biosciences (NBP) Free cash flow 2019–2025
NovaBridge Biosciences (NBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.6MFY2025 · since FY2019: -$126.4M → -$20.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.6M | +60.9% |
| FY2024 | -$52.7M | +71.3% |
| FY2023 | -$184.0M | -13.6% |
| FY2022 | -$162.0M | -2.9% |
| FY2021 | -$157.4M | -341.3% |
| FY2020 | $65.2M | +151.6% |
| FY2019 | -$126.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice